Diana DeGette

• HRES 1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Referred to the House Committee on Energy and Commerce. · 2026-05-14
• HR 8432 To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes. Referred to the House Committee on Energy and Commerce. · 2026-04-22
• HR 7425 Colorado Wilderness Act of 2026 Referred to the House Committee on Natural Resources. · 2026-02-09
• HR 7173 Follow the Science Act Referred to the House Committee on Energy and Commerce. · 2026-01-21
• HR 6082 Fracturing Responsibility and Awareness of Chemicals Act of 2025 Referred to the House Committee on Energy and Commerce. · 2025-11-18
• HR 5621 Physical Therapist Workforce and Patient Access Act of 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · 2025-09-30
• HR 5461 Special Diabetes Program Reauthorization Act of 2025 Referred to the House Committee on Energy and Commerce. · 2025-09-18

Showing up to 7 most recent bills sponsored in the 119th Congress. Data from Congress.gov.